Clinical Trial Update: Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing esomeprazole 20 mg or 40 mg with placebo to prevent peptic ulcers in subjects taking low-dose aspirin; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Peptic Ulcer Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Ulcer, Duodenal Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2012-02-13